The conference theme is ‘Biotechnology and The Future of Neuro-Oncology’ reflecting the exciting advancements that are taking place at the interface between neuro-oncology, biology and technology, and providing new hope for patients with brain cancer.

Building on previous congresses the programme will address the opportunities and challenges that have emerged in the field of biotechnology in recent years. BNOS 2025 will provide you with the latest insights and best practices in this rapidly evolving field.

You will benefit from a rich and diverse programme that covers all aspects of neuro-oncology research and practice, from basic science to emerging technology, and all aspects of clinical practice. We have a host of international and national keynote speakers who are worldwide leaders in neuro-oncology. See list of our speakers below or visit out speakers page for more information.

2025 Outline Programme – download here

Keynote Speakers

Gabriele Bergers | University of Leuven | Belgium

Shawn Hervey-Jumper | University of California San Francisco | USA

Parashkev Nachev | University College London | UK

Mario Luca Suvà | Harvard University | USA

Frank Winkler | University of Heidelberg | Germany

Confirmed Faculty

Marta María Alonso Roldán | Clinca Universidad de Navarra | Pamplona, Spain

Rebecca Campbell-Jones | University College London | UK

David Capsey | University College London | UK

Sarah Casey | University College London | UK

Seema Dadhania | Imperial Healthcare NHS Trust | UK

Jamie Dean | University College London | UK

Annick Desjardins | Duke Cancer Institute | USA

Danielle Fairweather | University College London | UK

Marta Ferri | University College London | UK

Laura Fitzpatrick | University College London | UK

Dr Karin Gehring | Tilburg University | Netherlands

Abby Harper-Payne | Imperial Healthcare NHS Trust | UK

Ahmed Id Baih | University Hospitals Pitié Salpêtrière – Charles Foix | France

Shelley Jones | Kings College Hospital NHS Foundation Trust | UK

Chris Jones | The Institute of Cancer Research | UK

Brieuc Lehmann | University College London | UK

Sara Melhuish | Barts Health NHS Trust | UK

Thomas Millner | University College London | UK

Samantha Mills | Walton Centre NHS Foundation Trust | UK

Florent Mouliere | Cancer Research UK Manchester Institute | UK

Jessica O’Brien | University College London | UK

Marco Palombo | Cardiff University | UK

Gita Ramdharry | University College London | UK

Shanika Samarasekera | University Hospitals Birmingham NHS Trust | UK

Charlotte Smith | The Christie NHS Foundation Trust | UK

Magdalena Sokolska | University College London | UK

Shivani Soni | Imperial Healthcare NHS Trust | UK

Lucy Stead | University of Leeds | UK

Aoife Stone-Ghariani | University College London | UK

Karin Straathof | University College London | UK

Clare Toner | University College London | UK

Martin van den Bent | Erasmus MC Cancer Center in Rotterdam | Netherlands

Rhona Watson | Oxford University Hospitals NHS Foundation Trust | UK

Matt Williamson | Imperial Healthcare NHS Trust | UK

Steve Williamson | National Institute for Health and Care Excellence | UK